Neuroimaging & Brain MeasuresDepressive DisordersAnxiety Disorders

Investigating Emotional Reactivity in Experienced Users of Psychedelics: a cross-sectional fMRI study

In a preregistered cross-sectional fMRI study comparing experienced naturalistic psychedelic users (≥10 lifetime uses; N = 33) with matched non‑users (N = 34), users were faster and more accurate at recognising angry faces, suggesting reduced interference from threat-related stimuli. Neuroimaging showed diminished limbic and salience‑network responses to anger, enhanced parietal and sensorimotor responses to happiness, increased precuneus activation to fear, and reduced emotional‑category differentiation in the frontal medial cortex and parahippocampal gyrus, indicating sustained neurofunctional alterations in emotional processing associated with naturalistic psychedelic use.

Authors

  • Paweł Orłowski
  • Michał Bola

Published

Human Brain Mapping
individual Study

Abstract

Classic psychedelics profoundly alter emotional states, inducing intense acute experiences lasting hours, followed by subtler, longer-lasting changes in emotional reactivity that can persist for weeks. While experimental and clinical studies document these prolonged effects, the highly context-dependent nature of psychedelic experiences leaves open the question of whether naturalistic, nonclinical use similarly modulates emotional processing. To investigate this, we conducted a preregistered, cross-sectional fMRI study comparing experienced psychedelic users (≥ 10 lifetime uses; N = 33) with closely matched nonusers (N = 34). Participants performed an emotional face recognition task, and we examined behavioral performance and neural responses to angry, happy, and fearful facial expressions. Behavioral results revealed that psychedelic users recognized angry expressions more quickly and accurately, indicating enhanced processing efficiency for threat-related stimuli. Consistent with this, whole-brain fMRI analyses showed reduced activation to anger in key limbic and salience network regions. Psychedelic users also exhibited heightened responses to happy expressions in parietal and sensorimotor cortices-aligning with prior clinical observations-as well as increased precuneus activation to fearful expressions. Region-of-interest analyses further demonstrated reduced differentiation between emotional categories in two default mode network nodes: the frontal medial cortex and parahippocampal gyrus. These findings provide a nuanced characterization of neurofunctional changes in emotional processing linked to repeated naturalistic psychedelic use. By bridging clinical and real-world contexts, this work deepens our understanding of the potential long-term consequences of psychedelics and complements existing evidence from controlled therapeutic settings.

Available with Blossom Pro

Research Summary of 'Investigating Emotional Reactivity in Experienced Users of Psychedelics: a cross-sectional fMRI study'

Introduction

Classic psychedelics such as psilocybin, LSD and DMT are known to alter perception, mood and cognition, and growing experimental and clinical evidence suggests they can produce sustained changes in emotional reactivity that may underlie improvements in well-being, depression and anxiety. Previous controlled studies have reported acute and subacute reductions in responses to negative emotional stimuli, including decreased amygdala reactivity, and alterations in large-scale networks such as reduced Default Mode Network (DMN) and Salience Network (SN) activity. However, most of these data derive from tightly controlled therapeutic or laboratory contexts with screening, standardised dosing and psychological support, leaving open the question of whether naturalistic, less-controlled psychedelic use produces similar persistent neural and behavioural effects. Orłowski and colleagues set out to address this gap by comparing experienced naturalistic psychedelic users to matched non-users on behavioural and fMRI measures during an emotional face classification task. The preregistered, cross-sectional study tested whether regular users (operationalised as ≥10 lifetime psychedelic experiences) differ from non-users in neural reactivity to negative versus positive facial expressions, with the primary hypothesis that users would show attenuated neural responses to negatively valenced stimuli, reflecting persistent modulation of emotion-processing circuits.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Pro members can view the original manuscript directly in the browser.

Study Details

References (20)

Papers cited by this study that are also in Blossom

Phenomenology, Structure, and Dynamic of Psychedelic States

Preller, K. H., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)

Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders

Vollenweider, F. X., Preller, K. H. · Nature Reviews Neuroscience (2020)

Long-term effects of psychedelic drugs: A systematic review

Aday, J. S., Mitzkovitz, C. M., Bloesch, E. K. et al. · Neuroscience and Biobehavioral Reviews (2020)

Emotions and brain function are altered up to one month after a single high dose of psilocybin

Barrett, F. S., Doss, M. K., Sepeda, N. D. et al. · Scientific Reports (2020)

Psilocybin, psychological distress, and suicidality

Hendricks, P. S., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2015)

84 cited
Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers

Kraehenmann, R., Preller, K. H., Scheidegger, M. et al. · Biological Psychiatry (2015)

Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects

Mueller, F., Lenz, C., Dolder, P. C. et al. · Translational Psychiatry (2017)

Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin

Carhart-Harris, R. L., Leech, R., Williams, T. M. et al. · British Journal of Psychiatry (2018)

202 cited
Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin

Lebedev, A. V., L€ Ovd En, M., Rosenthal, G. et al. · Human Brain Mapping (2015)

Show all 20 references
Psychedelics and the essential importance of context

Carhart-Harris, R. L., Roseman, L., Haijen, E. C. H. M. et al. · Journal of Psychopharmacology (2018)

Patients’ accounts of increased “Connectedness” and “Acceptance” after psilocybin for treatment-resistant depression

Watts, R., Day, C. M., Krzanowski, J. et al. · Journal of Humanistic Psychology (2017)

Neural Mechanisms and Psychology of Psychedelic Ego Dissolution

Stoliker, D., Egan, G. F., Friston, K. J. et al. · Pharmacological Reviews (2022)

Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression

Stroud, J., Freeman, T. P., Leech, R. et al. · Psychopharmacology (2017)

88 cited
Trial of Psilocybin versus Escitalopram for Depression

Carhart-Harris, R. L., Giribaldi, B., Watts, R. et al. · New England Journal of Medicine (2021)

927 cited
The challenges ahead for psychedelic ‘medicine’

Muthukumaraswamy, S., Forsyth, A., Sumner, R. L. · Australian and new-zealand Journal of Psychiatry (2022)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.

Investigating Emotional Reactivity in Experienced... — Research Summary & Context | Blossom